New Monoclonal Antibodies & Immunotherapies treatments in trials
Pembrolizumab, Nivolumab, Adalimumab — targeted oncology & autoimmune biologics. Track the treatments still in clinical testing and see which are closest to an FDA decision.
1,572Closest to approval (Phase 3)
5,863Mid-stage (Phase 2)
3,715Early stage (Phase 1)
18,825Total recruiting
In one line
18,825 monoclonal antibodies & immunotherapies trials are recruiting right now, 1,572 of them in Phase 3 — the stage immediately before an FDA decision.
Recruiting now
Twelve of the currently recruiting studies. Open one for a plain-English summary of who it is for and what it involves.
NCT06934057Phase 4RecruitingCabozantinib and Nivolumab Among Older Patients With Renal Cell CarcinomaSummary NCT07007312Phase 3RecruitingStudies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AMLSummary NCT07561567RecruitingFeasibility and Effectiveness of Respiratory Movement Management in Lung Cancer Receiving Stereotactic Radiotherapy Using a Novel Positional Fixation DeviceSummary NCT07222800Phase 3RecruitingSymbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal CancerSummary NCT06645236NARecruitingDHF-20-1839-2: Clinical Performance Study Protocol for Therascreen® KRAS RGQ PCR KitSummary NCT07819136Phase 1, Phase 2RecruitingREC-7735 in Participants With Solid TumorsSummary NCT06287944Phase 1Recruiting225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic SyndromeSummary NCT04590664Phase 1, Phase 2RecruitingVerteporfin for the Treatment of Recurrent High Grade EGFR-Mutated GlioblastomaSummary NCT05620732NARecruitingTreatment of Advanced Malignant Solid Tumors With Claudin18.2CAR-TSummary NCT07226999Phase 2, Phase 3RecruitingSymbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung CancerSummary NCT07210632EARLY_Phase 1RecruitingWindow Trial of Fluorescently Labeled Nivolumab-IRDye800 (Nivo800) in High Grade Glioma (HGG)Summary NCT05884632NARecruitingDaily Adaptive RadioTherapy in Postoperative HypofrActionated Salvage radiothERapy for Prostate Cancer PatientsSummary
Already approved for this area
Monoclonal Antibodies / Immunotherapies
Keytruda, Opdivo, Humira, Dupixent — approved products with their NDC records and billing codes.
Open the class
Every NDC in this class
The FDA registry filtered to monoclonal antibodies / immunotherapies, with packaging and 11-digit billing conversions.
Search the directory
Loading the trial explorer…